Biocodex expands its presence in Asia with the official launch of its Vietnamese subsidiary
– From Its Origins To Our Future
The inauguration ceremony of Biocodex Vietnam Co., Ltd. will take place on April 4, 2025, at Empress Tower (138-142 Hai Ba Trung, Da Kao, District 1, Ho Chi Minh City). This inauguration marks a new chapter for Biocodex in Asia, reinforcing its commitment to advancing healthcare solutions and supporting Vietnam’s growing healthcare sector.
Ho Chi Minh City, March 20, 2025 – Biocodex, a French family-owned pharmaceutical group operating in over 100 countries, officially announces the establishment of Biocodex Vietnam Co., Ltd. The inauguration ceremony will be held on April 4, 2025, at the company’s headquarters, in Ho Chi Minh City, making a significant step in Biocodex’s expansion in Asia
A legacy rooted in Vietnam; a future built for growth
Founded in 1953, Biocodex is a global healthcare player, renowned for pioneering the development of Saccharomyces boulardii CNCM I-745, the world’s first probiotic yeast strain dedicated to gut microbiome health.Inspired by the discovery of this probiotic strain in Vietnam by French biologist Henri Boulard in the 1920s, Biocodex has chosen Vietnam as the first country in the Asia-Pacific region to establish a subsidiary. This expansion highlights the country’s remarkable growth potential and its strategic importance in Biocodex’s long-term vision.
Commitment to Health and Innovation in Vietnam
Biocodex Vietnam is dedicated to delivering innovative solutions in three key healthcare areas:
✔ Gut Microbiota Health – advancing digestive well-being through probiotics
✔ Women’s Health – providing specialized solutions for women’s unique healthcare needs
✔ Orphan Diseases – supporting patients with rare conditions through targeted treatments
To ensure broad and safe access to high-quality healthcare solutions, Biocodex Vietnam is committed to collaborating closely with Vietnamese health authorities, healthcare professionals, and local partners.
A milestone event bringing together key stakeholders
The inauguration ceremony of Biocodex Vietnam Co., Ltd. will take place on April 4, 2025, at Empress Tower (138-142 Hai Ba Trung, Da Kao, District 1, Ho Chi Minh City). The event will be attended by representatives of Biocodex Group leadership, medical experts, strategic partners, honored guests (or and Vietnamese health authorities.), and press media.
This inauguration marks a new chapter for Biocodex in Asia, reinforcing its commitment to advancing healthcare solutions and supporting Vietnam’s growing healthcare sector. It also provides an opportunity for Biocodex to officially introduce its long-term strategy in Vietnam, reinforcing its mission to deliver high-quality pharmaceutical products tailored to the evolving needs of Vietnamese patients.
Information on the Launch Event of Biocodex Vietnam Co., Ltd.
- 11:00 – 11:05: Welcoming guests and experiencing Biocodex information booth
- 11:15 – 11:20: Opening speech by Biocodex Representative
- 11:20 – 11:30: Introduction of development strategy in Vietnam
- 11:30 – 11:40: Speech by Representative of the Ministry of Health of Vietnam
- 11:40 – 11:50: Inauguration ceremony in Biocodex Vietnam office
- 11:50 – 12:10: Interaction and Q&A
- 12:10 – 13:00: Closing, champagne, and commemorative photos
For more detailed information, please contact: [email protected]